Alere meets conditions for Axis-Shield takeover

Alere ($ALR) has claimed victory in its hostile takeover bid for medical diagnostic kit maker Axis-Shield. However, it had not yet conducted due diligence on the company. "Alere did no due diligence on Axis-Shield," a spokeswoman for Jefferies explained. "The offer has just gone unconditional, so the transaction process will go through." Jeffries is Alere's adviser for the deal. Item

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.